Metformin Use Is Associated with Decreased Mortality in COVID-19 Patients with Diabetes: Evidence from Retrospective Studies and Biological Mechanism

Background and Aims: The coronavirus disease 2019 (COVID-19) increases hyperinflammatory state, leading to acute lung damage, hyperglycemia, vascular endothelial damage, and a higher mortality rate. Metformin is a first-line treatment for type 2 diabetes and is known to have anti-inflammatory and im...

Descripción completa

Detalles Bibliográficos
Autores principales: Poly, Tahmina Nasrin, Islam, Md. Mohaimenul, Li, Yu-Chuan (Jack), Lin, Ming-Chin, Hsu, Min-Huei, Wang, Yao-Chin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397144/
https://www.ncbi.nlm.nih.gov/pubmed/34441802
http://dx.doi.org/10.3390/jcm10163507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397144/
https://www.ncbi.nlm.nih.gov/pubmed/34441802
http://dx.doi.org/10.3390/jcm10163507

Ejemplares similares